News

Anal cancer is relatively uncommon, accounting for approximately 2.5% of all gastrointestinal cancers. Nonetheless, its ...
Study authors examined the diagnostic utility of radiologic imaging for patients with high-risk cutaneous squamous cell carcinoma.
Several companies are advancing treatments for anal cancer, including Merck (KEYTRUDA), BioMimetix (BMX-001), Novartis (KFA115), and Bicara Therapeutics (BCA101), among others. As immunotherapy ...
Who doesn't love spending more time in the summer sun? However, it's important to protect your skin and check for signs of ...
A new transdermal from Medicus Pharma patch delivers a cost effective, efficacious, easy-to-administer treatment ...
Proteomics is getting to the pointy end with its Promarker Endo test for endometriosis, to replace current invasive diagnosis ...
That radiant glow you’re chasing by soaking up the sun could be doing more harm than good by raising your risk for skin ...
A single mum has shared the incredibly subtle sign of her skin cancer that struck twice, and resulted in a 'big gaping black ...
DelveInsight’s Natural Killer (NK)-Cell Lymphoma Pipeline report depicts a robust space with 100+ active players working to develop 140+ pipeline therapies for Natural Killer (NK)-Cell Lymphoma ...